A phase II study of interleukin-2 and lymphokine-activated killer cells in patients with metastatic malignant melanoma
J. P. Dutcher, S. Creekmore, G. R. Weiss, K. Margolin, A. B. Markowitz, M. Roper, D. Parkinson, N. Ciobanu, R. I. Fisher, D. H. Boldt, J. H. Doroshow, A. A. Rayner, M. Hawkins, M. Atkins
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'A phase II study of interleukin-2 and lymphokine-activated killer cells in patients with metastatic malignant melanoma'. Together they form a unique fingerprint.